The incidence of cardiomyopathy in BRCA1 and BRCA2 mutation carriers after anthracycline-based adjuvant chemotherapy
Crossref DOI link: https://doi.org/10.1007/s10549-016-4101-8
Published Online: 2017-01-09
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pearson, Edward J.
Nair, Anju
Daoud, Yahya
Blum, Joanne L.
Funding for this research was provided by:
Baylor Health Care System Foundation
License valid from 2017-01-09